Study number 8543-771
Still Enrolling! Healthy Males and Females needed
Dates
May 29 2025-Sep 12 2025
Location
Dallas, Texas
Age
18-64
Gender
Both Males and Females
Smoker
Yes
Compensation
$19,500
Group
1e
Study Details
This is a research study for an investigational drug being developed as a supplement to a reduced calorie diet and increased physical activity for long-term weight management. Tirzepatide is an injectable prescription drug that has been approved by the FDA for chronic weight management, in addition to diet, exercise, and oral (by mouth) medications. The use of tirzepatide in combination with the study drug in this study is investigational.
Fortrea Dallas, TX is recruiting for:
-Healthy Males and Females, age 18-64
-Body Mass Index between 22-30
-Study involves 2 separate stays totaling 12 nights & 11 follow-up visits*
-Compensation up to $19,500 may be provided for time and participation
-Refer a friend to receive $350 per qualified referral
*2 Additional inpatient or outpatient visits may be required.
Additional Details
1e:
Check-in: May 29, Jun 19
Check-out: Jun 4, 25
OPV: Jun 6, 9, 13, 27, Jul 4, 11, 18, Aug 1, 15, 29, Sep 12